Biotech and Pharmaceuticals

Why Eli Lilly’s Obesity Pill Is Still a Strong Contender Against Novo’s Wegovy Despite Mixed Investor Reactions
Eli Lilly’s stock has been on a rollercoaster ride recently. It took a hit after the company released data on ... Read more

Transform Your Health: FDA Approves Signos’ Revolutionary Glucose Monitoring System for Weight Loss!
The FDA recently approved Signos’ innovative glucose monitoring system designed specifically for weight loss. This marks a significant step for ... Read more

Save Big: Novo Nordisk Slashes Ozempic Prices for Cash-Paying U.S. Diabetes Patients
Novo Nordisk recently announced a significant price drop for Ozempic, their diabetes treatment. This move reflects growing pressure on drugmakers ... Read more

Eli Lilly Boosts 2025 Forecast with Soaring Mounjaro and Zepbound Sales: Quarterly Results Exceed Expectations!
Eli Lilly recently announced impressive second-quarter results, surpassing expectations mainly due to strong sales of its weight loss and diabetes ... Read more

Eli Lilly’s Breakthrough Obesity Pill Achieves 12% Weight Loss in Key Late-Stage Trial: A Game Changer for Weight Management
Eli Lilly recently shared exciting news about its new weight loss pill. In a late-stage trial, the highest dose helped ... Read more

Trump Warns: Pharma Tariffs Could Soar to 250%—What This Means for You
President Donald Trump recently discussed potential tariffs on imported pharmaceuticals during an interview with CNBC. He mentioned that these tariffs ... Read more